Floquet A - Search Results

1

First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment?

Debled M, Madranges N, Trainaud A, Floquet A, Donamaria C, Brouste V, Durand M, Mauriac L. Debled M, et al. Among authors: floquet a. Oncology. 2009;77(5):318-27. doi: 10.1159/000260904. Epub 2009 Nov 23. Oncology. 2009. PMID: 19940523

2

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.

Sertier AS, Ferrari A, Pommier RM, Treilleux I, Boyault S, Devouassoux-Shisheboran M, Kielbassa J, Thomas E, Tonon L, Le Texier V, Charreton A, Morel AP, Floquet A, Joly F, Berton-Rigaud D, Ferron G, Arnould L, Croce S, Bataillon G, Saintigny P, Mery-Lamarche E, Sagan C, Senaratne AP, Gut IG, Calvo F, Viari A, Ouzounova M, Ray-Coquard I, Puisieux A. Sertier AS, et al. Among authors: floquet a. Cancer Res Commun. 2023 May 10;3(5):830-841. doi: 10.1158/2767-9764.CRC-22-0520. eCollection 2023 May. Cancer Res Commun. 2023. PMID: 37377900 Free PMC article.

3

A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma.

Caudry M, Bonnel C, Floquet A, Marsault C, Quétin P, Pujol J, Maton O, Dujols JP, Caudry Y, Skawinski P, et al. Caudry M, et al. Among authors: floquet a. Am J Clin Oncol. 1995 Apr;18(2):118-25. doi: 10.1097/00000421-199504000-00005. Am J Clin Oncol. 1995. PMID: 7900703 Clinical Trial.

4

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS).

Mauriac L, MacGrogan G, Avril A, Durand M, Floquet A, Debled M, Dilhuydy JM, Bonichon F. Mauriac L, et al. Among authors: floquet a. Ann Oncol. 1999 Jan;10(1):47-52. doi: 10.1023/a:1008337009350. Ann Oncol. 1999. PMID: 10076721 Free article. Clinical Trial.

5

Neoadjuvant tamoxifen for hormone-sensitive non-metastatic breast carcinomas in early postmenopausal women.

Mauriac L, Debled M, Durand M, Floquet A, Boulanger V, Dagada C, Trufflandier N, MacGrogan G. Mauriac L, et al. Among authors: floquet a. Ann Oncol. 2002 Feb;13(2):293-8. doi: 10.1093/annonc/mdf037. Ann Oncol. 2002. PMID: 11886008 Free article.

6

DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer.

MacGrogan G, Rudolph P, Mascarel Id Id, Mauriac L, Durand M, Avril A, Dilhuydy JM, Robert J, Mathoulin-Pélissier S, Picot V, Floquet A, Sierankowski G, Coindre JM. MacGrogan G, et al. Among authors: floquet a. Br J Cancer. 2003 Aug 18;89(4):666-71. doi: 10.1038/sj.bjc.6601185. Br J Cancer. 2003. PMID: 12915875 Free PMC article.

7

[Laparoscopic interiliacal lymphadenectomy in cancer of the uterine cervix: still the gold standard? A propos lymph node recurrences in 190 treated patients].

Dekindt C, Stoeckle E, Thomas L, Floquet A, Kind M, Brouste V, Tunon de Lara C, MacGrogan G. Dekindt C, et al. Among authors: floquet a. J Gynecol Obstet Biol Reprod (Paris). 2005 Sep;34(5):473-80. doi: 10.1016/s0368-2315(05)82855-8. J Gynecol Obstet Biol Reprod (Paris). 2005. PMID: 16142138 Free article. French.

8

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.

Goncalves A, Fabbro M, Lhommé C, Gladieff L, Extra JM, Floquet A, Chaigneau L, Carrasco AT, Viens P. Goncalves A, et al. Among authors: floquet a. Gynecol Oncol. 2008 Jan;108(1):42-6. doi: 10.1016/j.ygyno.2007.07.057. Epub 2007 Nov 5. Gynecol Oncol. 2008. PMID: 17980406 Clinical Trial.

9

Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis.

Debled M, Houédé N, Madranges N, Donamaria C, Floquet A, Durand M, Mauriac L. Debled M, et al. Among authors: floquet a. Br J Cancer. 2007 Dec 17;97(12):1642-7. doi: 10.1038/sj.bjc.6604094. Epub 2007 Nov 13. Br J Cancer. 2007. PMID: 18000502 Free PMC article.

10

[Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix].

Goudy G, Stoeckle E, Thomas L, Kind M, Guyon F, Brouste V, Floquet A. Goudy G, et al. Among authors: floquet a. Bull Cancer. 2009 Jun;96(6):685-94. doi: 10.1684/bdc.2009.0873. Bull Cancer. 2009. PMID: 19467961 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters